Jesús K Yamamoto-Furusho1, Andrea Sarmiento-Aguilar2, Mario García-Alanis3, Luis Enrique Gómez-García2, Joel Toledo-Mauriño4, Laura Olivares-Guzmán2, Ana Fresán-Orellana5. 1. Clínica de Enfermedad Inflamatoria Intestinal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México. Electronic address: kazuofurusho@hotmail.com. 2. Clínica de Enfermedad Inflamatoria Intestinal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México. 3. Departamento de Neurología y Psiquiatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México. 4. Clínica de Enfermedad Inflamatoria Intestinal, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México; Plan de Estudios Combinados en Medicina (PECEM), Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Ciudad de México, México. 5. Subdirección de Investigación Clínica, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Ciudad de México, México.
Abstract
INTRODUCTION: The Hospital Anxiety and Depression Scale (HADS) is a self-administered instrument for outpatients, but its behaviour differs according to the clinical population to which it is applied. In Mexico it is not validated in patients with Inflammatory Bowel Disease (IBD). OBJECTIVES: To validate the HADS scale in the Mexican population with IBD. METHODS: 112 patients with IBD from the "Salvador Zubirán" National Institute of Medical Sciences and Nutrition were included, to whom the HADS was applied and some demographic and clinical characteristics of the disease were evaluated. An exploratory factor analysis was performed and factorial congruence was calculated to determine the construct validity of the HADS, while reliability was evaluated using Cronbach's alpha. RESULTS: The result of the varimax rotation of the 14 items of the HADS explained 50.1% of the variance, having two main factors. Ten items showed high factor loading for the dimensions originally proposed. The internal consistency of the HADS was high (alpha=0.88) with high values for the congruence coefficients. CONCLUSIONS: The HADS scale is a valid instrument to detect possible cases of Anxiety and Depression in Mexican patients with IBD. The validation of this instrument allows its routine use for the integral evaluation of the patient and their timely referral to mental health.
INTRODUCTION: The Hospital Anxiety and Depression Scale (HADS) is a self-administered instrument for outpatients, but its behaviour differs according to the clinical population to which it is applied. In Mexico it is not validated in patients with Inflammatory Bowel Disease (IBD). OBJECTIVES: To validate the HADS scale in the Mexican population with IBD. METHODS: 112 patients with IBD from the "Salvador Zubirán" National Institute of Medical Sciences and Nutrition were included, to whom the HADS was applied and some demographic and clinical characteristics of the disease were evaluated. An exploratory factor analysis was performed and factorial congruence was calculated to determine the construct validity of the HADS, while reliability was evaluated using Cronbach's alpha. RESULTS: The result of the varimax rotation of the 14 items of the HADS explained 50.1% of the variance, having two main factors. Ten items showed high factor loading for the dimensions originally proposed. The internal consistency of the HADS was high (alpha=0.88) with high values for the congruence coefficients. CONCLUSIONS: The HADS scale is a valid instrument to detect possible cases of Anxiety and Depression in Mexican patients with IBD. The validation of this instrument allows its routine use for the integral evaluation of the patient and their timely referral to mental health.
Authors: Miguel García-Grimshaw; Amanda Chirino-Pérez; Fernando Daniel Flores-Silva; Sergio Iván Valdés-Ferrer; María de Los Ángeles Vargas-Martínez; Ana Itiel Jiménez-Ávila; Oswaldo Alan Chávez-Martínez; Enrique Manuel Ramos-Galicia; Osvaldo Alexis Marché-Fernández; Martha Fernanda Ramírez-Carrillo; Samara Lissete Grajeda-González; Marco Eduardo Ramírez-Jiménez; Emma Adriana Chávez-Manzanera; María Teresa Tusié-Luna; Ana Ochoa-Guzmán; Carlos Cantú-Brito; Juan Fernandez-Ruiz; Erwin Chiquete Journal: Neurol Sci Date: 2022-01-13 Impact factor: 3.830
Authors: Jesús K Yamamoto-Furusho; Katya E Bozada Gutiérrez; Andrea Sarmiento-Aguilar; Ana Fresán-Orellana; Perla Arguelles-Castro; Mario García-Alanis Journal: Psychiatry J Date: 2021-10-27
Authors: Kaleb Bogale; Sanjay Yadav; August Stuart; Allen R Kunselman; Shannon Dalessio; Nana Bernasko; Andrew Tinsley; Kofi Clarke; Emmanuelle Williams; Matthew D Coates Journal: Inflamm Intest Dis Date: 2021-11-10